Bradley W.Harrison (Brad)

Brad Harrison is a trial lawyer who represents clients in product liability and complex civil litigation in courts and before arbitration panels throughout the United States. He is no stranger to the courtroom, having served as trial counsel in several jury trials and as a member of numerous other trial teams throughout the country. Brad was a member of the team that achieved the record-breaking patent infringement verdict for Idenix Pharmaceuticals (subsidiary of Merck & Co.). After a two-week trial, the jury ordered Gilead Sciences to pay $2.54 billion for its infringement of an Idenix patent related to the treatment of patients with hepatitis C infection. Brad is the administrative partner for the Business & Tort Litigation Practice in the Firm's Cleveland Office.

Brad devotes a large part of his practice to the defense of companies in product liability actions. He often defends companies in class actions and multidistrict litigation. Brad has successfully defended pharmaceutical and medical device manufacturers in cases involving prescription pharmaceuticals, stress urinary incontinence products, silicone gel breast implants, ultrasound-assisted and conventional liposuction equipment, and intraocular lenses. He also serves as counsel for R.J. Reynolds Tobacco Company in smoking and health litigation in Florida and throughout the country.

Brad also spends a considerable portion of his practice on commercial disputes, including complex business tort and contract litigation. These matters have included disputes regarding noncompetition agreements and business supply agreements as well as the representation of corporate policyholders in litigation against their insurers. In addition, Brad has been lead counsel for the defendant in a number of cases brought under the Fair Credit Reporting Act.